Page 2 - Ipid Management News Today

Bempedoic acid and bempedoic–ezetimibe are now indicated to prevent myocardial infarction and cardiovascular procedures in both primary- and secondary-prevention patients regardless of statin use.

Semaglutide improved MASLD in this population, and weight loss associated with its use resulted in no significant changes in physical function, according to two presentations at CROI.

The threshold of Lp(a) linked to increased risk for cardiovascular events may be different for primary and secondary prevention populations, new data suggested.

Higher dietary and supplemental vitamin E intake was associated with lower odds of having MASLD in a large cross-sectional study of US adults.

Despite lower prevalence rates, women with steatotic liver disease related to alcohol consumption had close to double the risk of dying than men with the same condition.

Data supported differences in triglycerides after a high-fat meal in women with OSA compared with men.

Two breakdown products from excess niacin, called 2PY and 4PY, were strongly associated with myocardial infarction, stroke, and other adverse cardiac events in multiple analyses.

Genetic testing for APOE would improve the prediction of atherosclerosis and enable the pursuit of aggressive strategies, said one researcher.

A retrospective analysis revealed a strong positive link between higher HDL-C levels and the reversal of prediabetes to normoglycemia in Chinese adults up to a certain threshold.

Investigators from the ongoing MAESTRO-NASH trial provided more evidence that resmetirom may be a viable option in a disease state currently without any approved treatments.